Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 146,055,657 | 135,304,032 | 122,553,876 | 102,801,334 | 118,306,745 | 625,021,644 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 146,055,657 | 135,304,032 | 122,553,876 | 102,801,334 | 118,306,745 | 625,021,644 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | 625,021,644 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 146,055,657 | 135,304,032 | 122,553,876 | 102,801,334 | 118,306,745 | 625,021,644 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 4,009,899 | 4,560,225 | 4,337,308 | 4,063,059 | 4,492,015 | 21,462,506 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 47,055 | 33,439 | 34,645 | 45,752 | 2,730 | 163,621 |
| 11 | Total support. Add lines 7 through 10 | 646,647,771 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2018 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2018 |
(iii) Distributable Amount for 2018 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2018 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2018: | ||||
| a From 2013....... | ||||
| b From 2014....... | ||||
| c From 2015....... | ||||
| d From 2016....... | ||||
| e From 2017....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2018 distributable amount | ||||
|
i
Carryover from 2013 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2018 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2018 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2019. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2014...... | ||||
| b Excess from 2015..... | ||||
| c Excess from 2016..... | ||||
| d Excess from 2017..... | ||||
| e Excess from 2018..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 18007340 |
| Software Version: | 19.1.1.0 |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4 | Connected for Life |
| Form 990, Part III, Line 4 | Today, more than 100 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting and debilitating disease that spans all ages, geography and educational levels. This chronic disease targets children, the elderly and minority populations more than others and costs the United States 327 billion dollars each year in lost productivity. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease and vision loss. The American Diabetes Association is the only organization dedicated specifically to the research, education and advocacy required to improve the lives of the 30.3 million adults and children in the U. S. with diabetes and the 84.1 million people with prediabetes. For 78 years, we have been working on the frontlines to educate at risk populations, protect the rights of people with diabetes at work, school and other aspects of daily life, pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. From research labs to the halls of the Capitol to the offices of health care practitioners to communities nationwide, we are there. We are bending the curve to help people living with diabetes and their families thrive. Why Because we envision a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Form 990, Part III, Line 4 | DIABETES RESEARCH |
| Form 990, Part III, Line 4 | Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that progressively lead to an inability to produce or effectively utilize insulin. The complexity of causes conspiring to diminish the bodys production or response to insulin, leading to high blood glucose and eventual development of diabetes, makes finding a single cure particularly difficult. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved patient care, resulting in fewer complications and better health outcomes for individuals with diabetes. As a leader in diabetes research, and the only organization dedicated specifically to the research, education and advocacy required to improve the lives of all people with diabetes, the American Diabetes Association funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our direct involvement in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the ADA with the framework and early leadership for a formalized diabetes research program. |
| Form 990, Part III, Line 4 | Since our Research Programs inception in 1952, we have been the leader in funding cutting edge diabetes research, supporting nearly 4,800 research projects and investing more than 834.4 million in diabetes research. In 2018, the ADA supported 318 new and continuing research projects at 104 leading research institutions across the United States. The projects cover the broad spectrum of research approaches, including basic, clinical and translational science and address all types of diabetes, diabetes related disease states and complications. The primary goals of the ADAs Research Program are to Support the highest quality science across the broad spectrum of diabetes research, Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research, Support innovative research with a high potential to have a significant impact for patients with diabetes. |
| Form 990, Part III, Line 4 | Peer Review Process. One of the factors that sets American Diabetes Association funded research apart and ensures that we are supporting the very best science is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field or peers of the individual submitting the grant. ADA grant applications all undergo peer review by three or more volunteer experts who are themselves diabetes researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is then used to determine which grants to support. |
| Form 990, Part III, Line 4 | Types of Research Awards. Research awards are divided into four major categories that reflect our research goals and priorities, provide extraordinary opportunities for researchers from diverse backgrounds, and foster the professional development of young scientists interested in diabetes research. The categories are Investigator-Initiated Awards Core Program Pathway to Stop Diabetes Collaborative Targeted Research and Research Co-Support. Approximately 80 percent of American Diabetes Association-funded research falls under the Core Research Awards. The ADA uses a single annual grant application cycle for its Core Research Program, featuring a streamlined grant portfolio. In 2018, a total of 884 research grant applications were submitted. With donor-directed funding, the ADA supported a targeted initiative in 2018 to fund three postdoctoral fellows with clinical or translational research projects focused on understanding the cardiovascular complications of type 1 diabetes. |
| Form 990, Part III, Line 4 | The ADA hosted a research symposium on the Use of Real-World Data to Improve the Prevention and Care of Diabetes-Related Outcomes in Washington D.C. in November of 2018. The symposium offered presentations and discussion with the goal of driving consensus to accelerate guidance on the design and use of real-world data to improve the prevention and care of diabetes-related outcomes. ADA-supported researchers made significant progress in understanding how diabetes develops and progresses, and in identifying new ways to combat the disease. Notable advances include assessing the potential of community programs to combat health disparities in type 2 diabetes a novel therapy to prevent type 1 diabetes leading to a better understanding of why the immune system attacks insulin-producing beta-cells in type 1 diabetes and preserving eyesight in people with diabetes by studying a unique molecule that seems to play an important role in the development of diabetic retinopathy, a progressive complication of diabetes that affects nearly 100 million people worldwide and leads to blindness. |
| Form 990, Part III, Line 4 | Research Program Outcomes. The American Diabetes Association-funded researchers show an exemplary commitment to advancing their careers within the field of diabetes research. Within five years of their award 99 percent of the researchers we fund remain committed to diabetes research for at least five years. 9 out of 10 researchers secure new funding within five years to expand their work, leveraging 7.36 for every 1 invested by the American Diabetes Association |
| Form 990, Part III, Line 4 | Pathway to Stop Diabetes. Launched in 2013, the American Diabetes Associations Pathway to Stop Diabetes initiative aims to inspire a new generation of diabetes researchers who are early in their career or are established but would like to expand their focus on diabetes research. Through awards of 1.625 million over the course of five to seven years, the program allows researchers to have the time and focus needed to explore new ideas. With a goal of funding 100 new diabetes researchers over the next decade, Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to new discoveries in diabetes prevention and treatment. Importantly, Pathway is in addition to ongoing ADA research activities and is significantly expanding our research efforts. Six new Pathway awardees began their research projects in January 2018. During the 2018 calendar year these new awardees, along with the 23 Pathway scientists who were continuing in their terms of Pathway funding, collectively published 30 high impact original research manuscripts and seven reviews. They delivered 151 presentations at scientific meetings. Through 2018, eight Pathway Initiator award recipients of nine funded to date have secured their first independent faculty positions. Ten patent applications have been filed by Pathway awardees to date. These outcomes demonstrate that the Pathway initiative continues to exceed its objectives and progress toward our vision of bringing 100 brilliant scientists to diabetes research. |
| Form 990, Part III, Line 4 | The Pathway scientists came together at the fourth annual Pathway to Stop Diabetes Symposium, held at the 78th Scientific Sessions in Orlando, Florida, where the newest cohort of Pathway awardees presented their project plans and progress to date. This exclusive symposium brought the awardees together with the Mentor Advisory Group, program sponsors, philanthropic supporters, and ADA leadership. The sixth annual Pathway to Stop Diabetes grant competition was held in 2018. The Mentor Advisory Group reviewed 89 outstanding nominations and selected three new Pathway awardees who began their grants in January 2018. With selection of these new awardees, the Pathway program has supported 32 outstanding investigators in total. 2018, the first group of scientists completed their terms of Pathway funding, which had started in 2014. These scientists, Kathleen Page, MD, of the University of Southern California Wolfgang Peti, PhD, of the University of Arizona and Joshua P. Thaler, MD, PhD, of the University of Washington, all completed their fifth and final year of their awards. Each of them has already added substantially to our understanding of diabetes and diabetes risk, and their contributions will continue throughout their careers in diabetes science, because they are now set up for success in conducting the kind of innovative, transformative research that holds promise to ultimately stop the health crisis that is diabetes. |
| Form 990, Part III, Line 4 | Scientific Sessions. Held annually, Scientific Sessions exemplifies the American Diabetes Associations leadership role in the global diabetes community, while providing a critical platform for driving diabetes awareness. Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. The 78th Scientific Sessions, held June 22 to 26, 2018 in Orlando, Florida, brought together more than 14,000 physicians, scientists, researchers, and health care providers. Over the course of five days, participants received exclusive access to more than 3,000 original research presentations, increasing their knowledge on the latest advances in diabetes research, care, and education. More than 3,000 abstracts were received. Of those received, 2,491 were presented as either Oral or Poster presentations. The remaining abstracts were either printed in the Journal Diabetes as Published Only or not accepted for presentation by the Scientific Sessions Meeting Planning Committee. |
| Form 990, Part III, Line 4 | 5th ANNUAL FOCUS ON FELLOWS. The 5th Annual Focus on Fellows program was held in conjunction with the 78th Scientific Sessions. This meeting is dedicated to fostering growth/development of future diabetes clinicians, researchers and leaders. The 131 attendees participated in a program that covered clinical, research and career development topics |
| Form 990, Part III, Line 4 | DIABETES IS PRIMARY. Diabetes Is Primary, an education program for primary care providers, was piloted in several markets in 2018. More than 600 primary care providers participated in these five pilots. Diabetes Is Primary was also held as a Scientific Sessions preconference. During 2018, more than 10,000 CE certificates were provided to individuals who participated in the programs webcasts. |
| Form 990, Part III, Line 4 | WIN ADA. The Womens Interprofessional Network of the American Diabetes Association WIN ADA, ADAs membership group for female clinicians, scientists, and educators in diabetes, grew significantly in 2018 from 400 to 2,000 members. This group held its first mini-symposium titled Overcoming Gender Gaps in Science, as well as an evening networking reception at the 78th Scientific Sessions, which approximately 300 professionals attended. |
| Form 990, Part III, Line 4 | INFORMATION |
| Form 990, Part III, Line 4 | Saving Lives through Knowledge. For people affected by or at risk for diabetes, having access to the most up-to-date tools and resources can literally make the difference between life and death. As a trusted leader, the American Diabetes Association works hard to ensure that those affected by and at risk for diabetes, their health care team as well as the general public receive targeted, timely and accurate information. We deliver resources that people can access any time in multiple formats including our website for consumers and professionals, diabetes.org, our flagship social media channels, and our professional journals and publications. We focus our efforts on three areas 1. Raising awareness of diabetes as a serious disease. 2. Ensuring patients, providers and care givers have tools and resources to effectively treat and manage diabetes 3. Reaching diverse groups of people who are at risk for or have diabetes, their families and health care professionals, with the goal of reducing the incidence of diabetes and the impact of complications. |
| Form 990, Part III, Line 4 | Center for Information. The ADAs Center for Information CFI at 1 800 DIABETES, marks the very first stop for many of our constituents as they start their journey of living with diabetes. The CFI processed nearly 100,000 contacts from constituents, professional members and others in 2018. Requests ranged from receiving information and resources for the care and management of diabetes, discrimination issues and enrolling in programs such as Living with Type 2 Diabetes, to inquiries about local and national ADA events, managing professional memberships and donations. CFI continued to support mission activities by Providing onsite support at trade shows and Scientific Sessions, Supporting the ADAs Hurricane Michael, Florence and Lane relief efforts, during regular and extended hours, including weekends, directing constituents and health care professionals to diabetes medication, food and other resources, Handling the logistics of the Living with Diabetes Ask the Expert Series, Collecting a total of 200,000 in donations, Distributing more than 40,000 packets of ADA produced information |
| Form 990, Part III, Line 4 | Digital Engagement. We offer a variety of targeted and interactive online properties to connect with our consumer and professional audiences, while providing the latest diabetes-related information and news. Through our website, diabetes.org, to our Diabetes Stops Here blog and ever-growing presence on Facebook, Twitter, YouTube, Pinterest and Instagram, the American Diabetes Association is connected to its constituents 24/7. Diabetes.org. Our website for consumers and professionals, diabetes.org, is widely regarded as the most informative and credible diabetes and nutrition resource on the Internet. In 2018, the site had 18 million sessions, 28 million unique pageviews, and 13 million new users. Professional.diabetes.org. DiabetesPro at professional.diabetes.org provides the latest resources in diabetes care and research for health care professionals and scientists. The mobile-friendly platform gives the ADA enhanced ability to deliver customized members-only content. DiabetesPro is the most advanced professional education website in any branch of medicine, giving those who have placed diabetes in the center of their careers the opportunity to stay informed and take advantage of various resources and educational offerings. Featured content includes Diabetes meetings and continuing education opportunities. News. Clinical practice recommendations. Webcasts and podcasts. Journals and books. Research grants. Recognition programs. Professional section interest groups |
| Form 990, Part III, Line 4 | Stopdiabetes.com. Stopdiabetes.com is the online hub of the American Diabetes Associations Stop Diabetes movement. The site invites visitors to pledge their support, add their name to the map and take action in the ADAs fight to Stop Diabetes. The sections include Ways to Act, Whats Happening, Get the Facts, Advocacy Center, and Donate Now. Social Media. The ADAs flagship social media channels continue to grow. Facebook fan base is now more than 727,000. Twitter following is up to 140,000. Pinterest following is over 13,000 with more than 62,000 monthly viewers. Instagram following is now over 28,000. LinkedIn continues to be a dedicated marketing communications channel for the professional audience. Our company page has more than 35,000 followers. The ADAs 78th Scientific Sessions generated more than 792 million media impressions worldwide. In 2018, the ADAs Diabetes Stops Here blog diabetesstopshere.org continued to publish regular, mission oriented content. Constituent acquisition through digital channels continued to be a major focus for the ADA in 2018. The ADA continued promoting the new Facebook Fundraisers tool with great success, raising more than 4.4 million dollars in 2018. |
| Form 990, Part III, Line 4 | Youth, Young Adult and Family Initiatives Reaching Type 1 and Type 2 Diabetes Families. For children living with type 1 diabetes, the everyday challenges of being a kid must be balanced with the management of a disease that is constant, demanding and scary. They walk a tightrope between blood glucose levels that are too high and those that are too low both of which can be life threatening. Because type 1 diabetes is a life-long disease and challenges vary at every stage of life, the American Diabetes Association strives to reach those with type 1 diabetes with relevant programs throughout their life from early diagnosis through adulthood and advanced management. The Youth, Young Adult and Family Initiatives team hosted a conference in October 2018 to examine and address the needs of rapidly advancing medical technology and data with the support of The Leona M. and Harry B. Helmsley Charitable Trust. At the conference, 41 stakeholders, including leaders from the ADAs camp network, the Diabetes Education and Camping Association DECA, industry representatives, ADA Youth and Family Initiative staff, and The Helmsley Charitable Trust convened in Arlington, Virginia to plan for the future. The goal was to share best practices and information to create a living document entitled, Best Practices for the use of Diabetes Technology at Summer Camps, and a set of training materials entitled, Diabetes Basics that are available for download at diabetes.org summercamp. |
| Form 990, Part III, Line 4 | Diabetes Camps. The American Diabetes Association continues to be the worlds largest provider of camps for children with diabetes. Our Diabetes Camps have become one of the most powerful and life changing avenues to improve the lives of children affected by diabetes. Offered each summer to nearly 6,000 youth with diabetes across the U.S., the overarching purpose of our Diabetes Camps is to promote diabetes self care in an environment thats fun, peer oriented and medically safe. Since 1947, these camps have provided a traditional summer camp experience while giving children the chance to master basic diabetes self management skills. At camp, children connect with peers facing the same daily struggles, build their confidence and overcome feelings of isolation and despair. Some campers learn how to inject insulin and count their own carbohydrates for the first time, while others advance their skills in insulin pump use. 2018 Diabetes Camp Highlights. The ADA hosted 80 Camp and Retreat sessions serving 6,677 children and teens and more than 10,000 of their loved ones. 2,019 campers were new in 2018. 2,661 volunteers made these programs possible. 1,553 trained medical professionals served as medical, dietary and social work staff during the summer season. The ADA also held five family retreats throughout the year, engaging parents and children who are newly diagnosed or new to the Camp community. The ADA continues to be the worlds largest provider of camps for children with diabetes. 5,689 of our 6,677 campers have type 1 diabetes. All camps offer camp fee subsidies for participants of 50 percent or more. In addition to this subsidy, 24 percent of our campers received need based financial aid and 535,974 dollars was awarded in 2018. This program ensures that the cost of camp is not a barrier for any family. |
| Form 990, Part III, Line 4 | Gaining New Diabetes Management Skills. After camp, 91 of campers were able to perform at least one diabetes management skill independently. Rotate injection sites 21 increase. Draw up insulin without assistance 20 increase. Recognize own low blood glucose levels 20 increase. Gave own injections 19 increase. Understand insulin to carb ratios 18 increase. Checked for ketones 18 increase. Changed pump site/sets 18 increase. Project Power. The ADA continues to take on the growing rates of type 2 in youth with Project Power, our healthy lifestyle intervention program for children at risk for type 2 diabetes and their families. 605 participants in Project Power 25 growth in 2018. 19 total programs 5 new in 2018. Project Power participants identified as 59 Latino, 19 African American, 9 Caucasian, 5 Multi Racial, and 8 Other with 37 of campers having a primary language other than English or Bilingual. |
| Form 990, Part III, Line 4 | Diabetes Disaster Response Coalition. The American Diabetes Association is a founding partner and convener of the Diabetes Disaster Response Coalition, a coordinated domestic disaster-response effort that also includes Insulin for Life USA, Juvenile Diabetes Research Foundation JDRF, the American Association of Clinical Endocrinologists AACE, the American Association of Diabetes Educators AADE, Beyond Type 1, the Diabetes Research Institute Foundation, the Endocrine Society, Insulet Corporation, The Leona M. and Harry B. Helmsley Charitable Trust, Lilly Diabetes, Sociedad Puertorriquena Endocrinologia Y Diabetologia SPED and T1D Exchange. The coalition was developed in 2017 following hurricanes Harvey, Irma, and Maria, in order to help make disaster-response efforts more efficient and responsive to the needs of people with diabetes. In 2018, the Coalition responded to seven hurricanes, storms, fires and disaster events and formalized the foundation of our work with the support of The Helmsley Charitable Trust. The Coalition is focused on its roles as educator, communicator, and advocate, leveraging its collective resources and influence to bring together the diabetes community, public agencies, disaster response organizations, retailers, elected officials, drug and device manufacturers and others to 1 prepare people with diabetes and their caregivers with the information and resources to remain healthy and safe during a disaster 2 remove road blocks to patient access to prescriptions and diabetes supplies during times of disaster 3 support and increase access to diabetes specialists to assist with diabetes care in shelters and other health care settings during times of disaster by sharing information between diabetes specialists/providers and those organizations that place volunteers on the ground and 4 serve as a communications hub during times of disaster, helping to identify and address unmet medical needs of people living with diabetes by connecting them to providers on the ground. |
| Form 990, Part III, Line 4 | Professional Education. The primary goal of our professional education program is to affect the quality of treatment and improve patient outcomes for people with diabetes by providing quality education for those health care professionals who provide their care. We conduct professional education activities directed toward enhancing knowledge, competence, advancing skills and apprising health care professionals of the latest developments in diabetes research and clinical practice. The American Diabetes Association has been accredited to provide continuing education to health care professionals for more than 30 years and is accredited by seven accrediting boards. The ADA remains in exemplary standing with each accrediting board proving our compliance with the continuing education guidelines. The ADA continues to be at the forefront of professional continuing education for the diabetes community as an accredited provider of continuing education credit for all health care professionals on the diabetes management team. In November of 2018, Professional Services Department received Joint Accreditation for Interprofessional Continuing Education for health care professionals, and the ability to offer Maintenance of Certification MOC credit to physicians through the American Board of Internal Medicine AIBM. The ADA was awarded Joint Accreditation for Continuing Interprofessional Education through the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education, and the American Nurses Credentialing Center. This designation allows the ADA to offer continuing education credit for physicians, nurses, pharmacists, physician assistants, psychologists and social workers. The intensive 18-month accreditation process included a self-study, an audit of the ADA and select programs, and an interprofessional interview with leaders of our Professional Education team and the accrediting boards. Based on our stellar programs, the ADA was awarded the maximum six-year accreditation term. |
| Form 990, Part III, Line 4 | Diabetes Is Primary An education program for primary care providers, Diabetes Is Primary, was piloted in several markets in 2018. More than 600 primary care providers participated in these five pilots. Diabetes Summit. On November 28, 2018, the ADA hosted a full-day in person summit in Arlington, Virginia entitled Overcoming Therapeutic Inertia Accelerating Diabetes Care For Life. More than 130 professionals from across the spectrum of health care including health systems, clinicians, industry, researchers, payors, diabetes non-profits, technology companies, and more attended. Presentations were comprehensive in scope and the audience of key stakeholders were extremely interactive. There were more than 200 comments received throughout the day. A steering committee, representing key stakeholder groups, met the following day and discussed the presentations and all feedback received. The committee and ADA senior leadership agreed that to maintain the momentum of this project, the ADA would publish a Summary of Proceedings in early 2019 and distribute it to all attendees and all ADA journal subscribers. This summary will include the key points made from each speaker, recommendations for the creation of work groups to immediately begin solving key identified problems, and a high-level roadmap of timing and next steps for the project. The latest information and updates will be available on https//professional.diabetes.org therapeuticinertia. The site includes a full roster of attendees, the summit agenda, and the presentations given at the summit. This is a multi year campaign to address and provide solutions to this long-standing problem. It will require all stakeholders working together to fix it. |
| Form 990, Part III, Line 4 | WIN ADA. The Womens Interprofessional Network of the American Diabetes Association WIN ADA, ADAs membership group for female clinicians, scientists, and educators in diabetes, grew significantly in 2018 from 400 to 2,000 members. The ADA also launched an online community for WIN ADA members within the DiabetesPro Forum, which will facilitate ongoing communication between women in the diabetes field and enhance the exchange of career development and womens health resources. Diabetes INSIDE. The ADAs Diabetes INSIDE continues to improve population health at participating health care systems. Parkland Health and Hospital system presented an oral session at ADAs 78th Scientific Sessions describing their Diabetes INSIDE experience and results. As part of the Know Diabetes by Heart initiative in partnership with the American Heart Association, Diabetes INSIDE has enrolled new health care systems with a focus on the mid Atlantic region to improve population health for people with diabetes and cardiovascular disease. Diabetes INSIDE has established multiple partnerships including the Jefferson College of Population Health, who will act as the academic partner for KDBH and host for live events, and HealthShare Exchange, a health information exchange that supports data sharing in the Greater Philadelphia health care market. |
| Form 990, Part III, Line 4 | Diabetes INSIDE has also received new funding from Abbott to support QI activities in therapeutic inertia, with a focus on Philadelphia health care systems. These partnerships will ultimately allow Diabetes INSIDE to realize a strategic goal to form a regional collaborative of health care stakeholders to improve diabetes population health. The Education Recognition Program ERP continues to operate as the largest and longest standing of the two Medicare National Accrediting Organizations NAO with 1,600 Diabetes Self Management Education and Support DSMES services, with more than 3,700 sites and over 800,000 patients are served in 2018. The 2017 National Standards for DSMES workgroup, convened by ADA and AADE, finalized their evidence review and standards revisions in 2017. The Standards were simultaneously published in the ADAs October issue of Diabetes Care and the fall issue of AADEs The Diabetes Educator. The ERP national committee revised the ADA interpretive guidance of the standards and Medicare accepted their revisions in late 2017. In 2018, all ERP website resources, audit toolkits, auditor training and monthly program calls were updated according to the 2017 National DSMES. Three successful DSMES symposia during 2018 San Francisco, California, Lowell, Massachusetts, and Greenville, South Carolina. This one day program guides attendees on establishing and maintaining an ADA recognized service that adheres to the 2017 National DSMES Standards. The ADA Diabetes Prevention Program Charting Platform DPP Express was launched in the spring of 2017 in response to Medicares announcement of the expansion of Medicare Part B reimbursable services to include the CDC Diabetes Prevention Program starting in 2018. This has provided ERP another opportunity to support our current and potential Recognized DSMES services. DPP Express captures the CDC required DPP data, DPP sessions, and generates the required CDC reports. The ERP adapted the online Recognition application to allow for virtual DSMES services to apply for National Virtual DSMES Recognition. The National Application was developed to align with the evolving delivery of DSMES which is changing rapidly with the advancement of technology. The ADA Prevention Program Charting Platform was launched in the spring of 2017 in response to Medicares announcement of the expansion of Medicare Part B reimbursable services to include the CDC Diabetes Prevention Program starting in 2018. This has provided ERP another opportunity to support our current and potential Recognized DSMES services. The charting platform captures the CDC required DPP data, DPP sessions, and generates the required CDC reports. The DPP charting platform adaptations to align with the CMS final DPP coverage ruling and the revised 2018 CDC DPP standards was an element included in the CDC grant awarded to the ADA in the fall of 2017. The platform is available to ERP and non ERP programs for a nominal fee. The ERP adapted the online Recognition application to allow for virtual DSMES services to apply for National Virtual DSMES Recognition. The National Application was developed to align with the evolving delivery of DSMES, which is changing rapidly with the advancement of technology. The National Application allows a virtual DSMES service to apply for DSMES Recognition in all 50 states with a single application versus 50 separate applications. This also streamlines the annual status reporting processes to one annual report rather than 50 separate reports. National DSMES Recognition follows the same DSMES standards application requirements as traditional recognition |
| Form 990, Part III, Line 4 | PUBLICATIONS. The American Diabetes Association is the leading authority in creating and publishing the worlds most respected consumer magazine, books, and professional journals about diabetes. Our award-winning monthly magazine, Diabetes Forecast, is the premier healthy living magazine for individuals affected by diabetes. Numerous books by well known and credentialed authors are published each year, including consumer-oriented books on diabetes treatment, self-care, nutrition, cooking and psychosocial issues, as well as a variety of titles for our professional readers, such as the frequently updated Medical Management Series. The ADA also publishes four highly valued professional journals, Diabetes, Diabetes Care, Clinical Diabetes and Diabetes Spectrum, as well as numerous articles, position and other professional papers. |
| Form 990, Part III, Line 4 | Professional Journals. The ADA continued to publish the leading scientific and medical journals related to the prevention and treatment of diabetes and diabetes complications. In 2018, Diabetes, Diabetes Care, Clinical Diabetes and Diabetes Spectrum reached more than 40,000 health care professionals, including researchers, physicians and diabetes educators, with information on cutting edge diabetes research, state of the art treatment advances and clinical treatment guidelines. The ADAs professional journals at www.diabetesjournals.org received more than 10 million visits and 20 million page views, and studies published in ADA journals were cited more than 120,000 times by studies published in other science and medical publications. The 2017 impact factors for Diabetes and Diabetes Care were released in July 2018. Diabetes Care achieved the highest impact factor ever recorded for an ADA journal 13.4 and Diabetes achieved an impact factor of 7.3. The two journals rank 5th and 9th, respectively, of 138 publications in the field of endocrinology/metabolism. In addition, according to Eigenfactor, a measure of a journals total importance to the scientific community, Diabetes Care and Diabetes are the top two journals devoted to diabetes research, and ranked 1st and 3rd, respectively, among the 143 journals indexed in the broader field of endocrinology and metabolism. In January 2018, the ADA published the Standards of Medial Care in Diabetes and the abridged version of the Standards of Care for primary care physicians in Diabetes Care and Clinical Diabetes, respectively. In addition to these critical resources for diabetes health care professionals, numerous ADA position and other professional papers were published in Diabetes Care in 2018, including ADA Statement Economic Costs of Diabetes in the US. https//doi.org/10.2337/dci18-0007 May 2018. ADA Statement Insulin Access and Affordability. https//doi.org/10.2337/dci18-0019 June 2018. ADA Statement Evaluation and Management of Youth-Onset Type 2 Diabetes. https//doi.org/10.2337/dci18-0023 September 2018. Position Statement Type 1 Diabetes in Children and Adolescents. https//doi.org/10.2337/dci18-0052 December 2018. ADA Consensus Statement Management of Hyperglycemia in Type 2 Diabetes ADA-EASD Consensus Report. https//doi.org/10.2337/dci18-0033 December 2018 |
| Form 990, Part III, Line 4 | Diabetes Forecast. The ADAs consumer magazine, Diabetes Forecast, published six issues in 2018, reaching nearly 6 million readers. It reaches people where they are at home with the print magazine, in their inboxes with a biweekly e newsletter, and wherever on the web. The magazine covered topics of interest to those living with diabetes and their families, including eating healthfully, staying active, preventing complications, and learning to best manage day to day diabetes related activities. In 2018, Diabetes Forecast magazine celebrated its 70th year of providing people with diabetes with relevant, accurate, and engaging information that helps them better manage their diabetes. Each issue throughout the year highlighted people with diabetes who have lived long lives with diabetes, focusing on topics like how diabetes treatment has changed in the past several decades, from medication advancements to new technology to innovations in diabetes education and awareness. In addition, Diabetes Forecast content was packaged into mini, advertiser backed supplements and included in select issues of the magazine. These supplements focused on topics of relevance to the Diabetes Forecast audience retinopathy, continuous glucose monitors, and pneumococcal vaccination. The magazine took first steps to integrate its recipe content with the ADAs Food Hub. In the print edition of Diabetes Forecast, the food section has been rebranded as Food Hub, and the Food Hub logo reinforces the connection between the two products. Recipes appearing in the magazine are now posted to Food Hub. |
| Form 990, Part III, Line 4 | Awareness Education. National Diabetes Prevention Program. The Centers for Disease Control and Prevention CDC awarded the ADA a five-year, DP17-1705 cooperative agreement to support the expansion of the National Diabetes Prevention Program National DPP to underserved areas in the U.S. In 2018, the ADA provided funding, technical assistance, and resources to six affiliate sites in five states including Arizona, California, Kansas, Oklahoma and Texas. The affiliate sites have worked to increase referrals from health care providers, increasing awareness and enrollment, improving retention rates, and developing agreements to cover the CDC-recognized lifestyle change program. In 2018, the ADA was instrumental in helping five affiliate sites apply for recognition with the CDC. Affiliate sites enrolled more than 600 new participants into lifestyle change programs, reached more than 138,600 people with messages of awareness and recruitment, and developed referral agreements with seven health care providers in their community. The cooperative agreement runs from September 30, 2017 through September 29, 2022. |
| Form 990, Part III, Line 4 | American Diabetes Month. Observed every November, American Diabetes Month ADM is an important element in the efforts of the ADA to focus the nations attention on diabetes and the tens of millions of people affected by it. Through the ADAs flagship awareness campaign, the ADA speaks directly to constituents and rally them to increase awareness and understanding of the prevalence of diabetes and the burden it places on individual lives. In 2018, the ADA partnered with Colgate Total and CVS Pharmacy to raise a unified voice for diabetes awareness through an integrated marketing and communications strategy. The result was a powerfully themed campaign Everyday Reality with messaging illustrating the everyday realities from the perspective of the person caring for or living with diabetes. The individuals shared their Everyday Reality to help people understand the daily management required for diabetes, but more importantly, to make them feel that diabetes is personally relevant and connected to them. The team promoted the campaign using paid media, earned media, ADA channels, and partner outreach. The campaign was incredibly successful with more than 472,000 in Facebook donations during November, the highest ever received through that channel. Additionally, the campaign garnered nearly 60,000 pageviews to the ADM landing page, and more than 3.5 million impressions through social media. |
| Form 990, Part III, Line 4 | Know Diabetes by Heart.The American Diabetes Association joined forces with the American Heart Association, along with other industry leaders to launch a collaborative initiative Know Diabetes by Heart to reduce cardiovascular deaths, heart attacks and strokes in people living with type 2 diabetes. With support from founding sponsors, the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors Sanofi and Astra Zeneca, the Know Diabetes by Heart initiative seeks to comprehensively combat the national public health impact of type 2 diabetes and cardiovascular disease by Raising awareness and understanding of the link between diabetes and cardiovascular disease. Positively empowering people to better manage their risk for cardiovascular disease, heart attacks and strokes. Supporting health care providers in educating their patients living with type 2 diabetes on cardiovascular risk and increasing their patients engagement in prevention of cardiovascular deaths, heart attacks and strokes. Learn more about the Know Diabetes by Heart initiative at knowdiabetesbyheart.org. |
| Form 990, Part III, Line 4 | Diabetes Food Hub. In May of 2018, the Products Department launched the Diabetes Food Hub, the new food and cooking platform designed specifically for people with diabetes. Working with a cross departmental team that represented Mission, Marketing and Communications, Legal, and Corporate Alliances, this platform was designed from the ground up based on the needs and requirements of those living with diabetes, their caregivers, and health care professionals. In 2018, the site had more than 500,000 visitors, 2 million pageviews, and 27,000 registered users, with an average audience growth of 19 percent month over month from May to December. Features of the new site include Hundreds of recipes that meet the ADAs nutrition guidelines, with new content published weekly. An interactive Meal Planner that allows home cooks to build out a week of meals, complete with nutrition information. Automatic and editable shopping lists. Advanced search capabilities, including filters and ingredient search. Dynamic profiles that retains user likes and dislikes over time. Advice and cooking tips from diabetes nutrition and cooking experts. |
| Form 990, Part III, Line 4 | Signature Campaigns. Our special events provide another opportunity for the American Diabetes Association to raise awareness about diabetes and are an integral part of our strategic vision to eradicate the disease. In 2018, all ADA events, including our signature events Step Out Walk to Stop Diabetes and Tour de Cure, incorporated our educational message to bring awareness of the seriousness of this diabetes epidemic. Our special events team formed our brand-new Do-It-Yourself platform, Team Diabetes, that allows constituents to turn their passion into a fundraiser for the American Diabetes Association through www.diabetes.org/teamdiabetes. Our top 64 Step Out Tour de Cure participants who raised 10,000 or more raised a total of more than 1 million. |
| Form 990, Part III, Line 4 | ADVOCACY |
| Form 990, Part III, Line 4 | Speaking Up for All People with Diabetes. The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Raising our voices from Capitol Hill to state houses to court houses across the country, our dedicated Diabetes Advocates continue to drive momentum in our ongoing fight to Stop Diabetes. Our advocacy work gives people with diabetes, their families and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state and national levels. Our primary goals are to increase federal and state funding for diabetes prevention, treatment and research, to prevent diabetes, to improve the availability of accessible, adequate and affordable health care. to end the discrimination people with diabetes face at school, work and elsewhere in their lives. |
| Form 990, Part III, Line 4 | We have trained advocates around the country who represent those with diabetes who need a raised voice to protect their rights. An ever-growing volunteer network of attorneys, health care professionals and advanced school advocates help thousands facing discrimination because of their diabetes. In 2018, the ADA Federally increased funding diabetes research and programs by nearly 170 million for Fiscal Years 2018 and 2019 and achieved a 600 million reauthorization of the Special Diabetes program, which supports critical research toward better treatments and a cure for type 1 diabetes and essential prevention and management programs for American Indians through Fiscal Year 2019. Increased funding for National Institute of Diabetes and Digestive and Kidney Diseases by over 159 million, for the Division of Diabetes Translation by 8 million and for the National Diabetes Prevention Program by 2.8 million in federal Fiscal Years 2018 and 2019. Achieved 600 million reauthorization of the Special Diabetes Program, which supports critical research toward better treatments and a cure for type 1 diabetes and essential prevention and management programs for American Indians through Fiscal Year 2019. Participated in hundreds of meetings, briefings events and other actions in support of our legislative and regulatory priorities which led to a record setting 80 legislative and regulatory wins in states across the country. Added two states to the 27 states already requiring diabetes action plans that assess the burden of diabetes and prioritize policy recommendations to reduce the burden of diabetes. Achieved 30 state level wins that advance prevention policies including school-based policies, community-based policies, and budget allocations that increase state investment in prevention programs. Mobilized Diabetes Advocates through our Congress at Home initiative to host nearly 60 in-district meetings across the country with Congressional members and their staff. More than 80 of the meetings were with targeted key congressional member offices those with direct influence and jurisdiction over ADA federal policy priorities and asks. Convened nearly 200 people living with and affected by diabetes, health care professionals, researchers, and 17 current and former professional football players at Call to Congress to advocate on Capitol Hill in Washington, D.C. for increased federal funding for diabetes research, affordable insulin and health care access and coverage and more. |
| Form 990, Part III, Line 4 | Helping Patients and Their Families Thrive. Achieved goal of congressional hearing on insulin affordability and delivered testimony to the Senate Special Committee on Aging about the rising cost of this lifesaving drug. Published a white paper with conclusions and recommendations to address this issue and a public policy statement outlining steps state and federal legislators and regulators can take to address rising insulin costs. Secured an additional 181,000 signatures for ADAs insulin affordability petition for a total of over 432,000 signatures. This ongoing campaign included the launch of a new animated video to explain the complexities of the insulin supply chain. Achieved 37 state level wins protecting or improving health care for millions of people with diabetes in states across the country. Continued efforts to protect the Affordable Care Act ACA by filing an amicus friend of the court brief defending the ACA against a lawsuit challenging the laws constitutionality. The brief, which was jointly filed with four other patient advocacy organizations, brought to the courts attention the ADAs significant interest in protecting the ACA for Americans impacted by diabetes. Introduced in the House and Senate for the first time the Expanding Access to Diabetes Self Management Training Act, which would remove barriers to Diabetes Self Management Education and Support in Medicare and encourage beneficiaries to participate in such programs. Educated and inspired action among our 525,000 advocates in more than 70 federal, state and legal advocacy calls to action throughout the year. Handled 2,005 discrimination cases, a record high in the 18 year history of the Legal Advocate Program. Much of the increase was noted in cases involving discrimination in the workplace, representing a 15 percent increase over 2017. |
| Form 990, Part III, Line 4 | Affirmed positive outcomes for individuals who received assistance from the Legal Advocate Program, such as increased knowledge of relevant laws and increased confidence in responding to discrimination. These outcomes were verified by data from a survey of constituents helped via ADA Safe at School campaign. Celebrated the publication of a Final Rule by the U.S. Department of Transportation, Federal Motor Carrier Safety Administration that eliminated a blanket ban against insulin use for commercial drivers with diabetes. This rule was the culmination of a 12 year rulemaking process and more than two decades of advocacy by ADA. Pursued litigation against the U.S. Army Child, Youth School Services on an appeal to the U.S. Court of Appeals for the Ninth Circuit and organized amicus curiae friend of the court support from a record 32 diabetes, disability, and civil rights organizations. Filed a class action lawsuit against the New York City public school system challenging discriminatory practices that violate the rights of children with diabetes by denying them the necessary services to safely attend school and even exclude them from some school activities. Improved access to continuous glucose monitors used with a mobile device for Medicare beneficiaries. Educated individuals with diabetes and prediabetes about health insurance coverage options and key factors to consider when enrolling. Increased access to nutritious foods through healthy food financing, school-based meal assistance programs, and other state-level health equity legislation that impacts communities across the country. Empowered advocates by launching three new Advocates in Action opportunities, including two webinars, Kids with Diabetes How ADA Helps and Advocacy in an Election Year Legal Dos and Donts of Advocacy, as well as a Local Media Blitz geared at placing opinion editorials in districts with newly elected officials written by Diabetes. |
| Form 990, Part III, Line 4 | We are Connected for Life. Just Imagine. The American Diabetes Association is a lot of things to a lot of different people. But the one thing we are to everyone is a connection point in the fight to cure diabetes to help people live a better life. Just imagine. Imagine the day when diabetes will no longer devastate our families and communities, our neighbors near and far. When a parent doesnt have to hear that their child has an incurable disease that brings with it not only sleepless nights, but constant fears about possible complications and diabetes related discrimination. When nobody has to worry anymore about blood glucose highs and lows and whether that blurred vision is the beginning of a life without sight. When a family can gather at a family reunion and create happy memories instead of having to gather at a graveside to say goodbye to a loved one who has lost their battle against diabetes. We know that, together, we can stop this dreadful disease and realize our vision life free of diabetes and all its burdens. Learn more at www.diabetes.org and www.stopdiabetes.com. |
| Form 990, Part III, Line 4 | Other Program Services revenue reported in Line 4d 1,723,746 relates to the investment in real estate. This investment represents a 1998 donor bequest that restricted the Association from selling the property for 25 years. A portion of the property is leased to corporations and derives monthly income that is reported in investment income. |
| Form 990, Part VI, Section A, Line 6, 7a | The American Diabetes Association has established the voting membership of the Association as the Voting Members. The Voting Members are comprised of all of the members of the Board of Directors and additional delegates. The Voting Members vote on the election of the organizations governing body each year. No governance decisions are reserved to or subject to approval by the membership. |
| Form 990, Part VI, Section B, Line 11 | IRS Review Process by the Governing Body The American Diabetes Association Board of Directors assigns the Audit Committee the oversight responsibility of the IRS Form 990 and its supplemental schedules prior to completion. After review by management and KPMG, the final signed 990 was provided to the Associations Board of Directors prior to filing with the IRS. |
| Form 990, Part VI, Section B, Line 12 | Managing Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, Officers, Directors, and members of select Board appointed committees and their related subcommittees, journal/periodical editors, and senior staff of the Association must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes. Through review of the annual disclosures and review of the agendas of the relevant Board ,Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Based on the situation, senior volunteers and staff presiding over the discussion are responsible to ensure appropriate action is taken for the individual to publicly disclose the conflict, for the individual to recuse him or herself from the discussion, vote or room as appropriate and to ensure the disclosure and action is documented in the minutes of the meeting. |
| Form 990, Part VI, Section B, Line 15a | Compensation Process Annually, The American Diabetes Association Principal Officers Chair of the Board President, Medicine Science President, Health Care Education and Secretary/Treasurer are responsible for establishing executive compensation consistent with the guidelines approved by the Compensation Committee. The Principal Officers of the Association use a Compensation Committee, compensation studies and an in dependent consultant to establish the compensation of the Chief Executive Officer and other Key employees. The Chief Executive Officer is responsible for the individual performance evaluations of staff officers and key employees, and establishes the total compensation for key employees subject to the guidelines established by the Executive Compensation Committee. The Executive Compensation Committee develops guidelines for the key employee executive positions listed below following the process described in the IRS intermediate sanctions rules when determining compensation. Specifically, the Committee 1 Is composed entirely of non-employee volunteer leaders who have no familial, business or significant personal relationships with the American Diabetes Association or its executives 2 Assesses the short-term and long-term contribution and performance of CEO and other senior executive employees in meeting very definitive and quantifiable objectives focused on the Associations mission success 3 Engages an independent compensation consulting firm to compile appropriate comparability data including compensation market information for peers with whom the American Diabetes Association competes for executive talent. 4 The Committee reviews this data in detail for all elements of each executives total compensation, including but not limited to base salary, bonuses, perquisites, fringe benefits, and incentive and deferred compensation arrangements. Upon the executives hire, and at each point in time thereafter at which a new or revised compensation arrangement is under consideration with respect to the executive, the Committee meets before the arrangement is implemented to evaluate the reasonableness of the arrangement by comparing both the arrangement itself and the executives entire compensation package to compensation packages paid by similarly situated organizations for functionally comparable positions 5 Documents, concurrently with its determination, the basis for its determination in the minutes of its meeting These minutes are reviewed, revised if necessary and approved at the following meeting of the Executive Compensation Committee. The process described above was used to establish compensation for the following positions Chief Executive Officer, Chief Field Development Officer, Chief Financial Officer, Chief Medical Officer, Chief Revenue Officer, Executive Vice President of Government Affairs Advocacy, Senior Vice President and Chief Technology Officer, Senior Vice President of Human Resources, Senior Vice President of Marketing Communications. The total compensation of executives at the American Diabetes Association is specifically designed to attract and retain the highest qualified executive talent to fulfill the critically important mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Form 990, Part VI, Section C, Line 17 | Filing Jurisdiction Registration Number Alabama-AL97-256, Alaska-N/A, Arizona-10145, Arkansas-N/A, California-CT81471, Colorado-2002-3003670, Connecticut-5084, District of Columbia-981855, Florida-CH1618, Georgia-CH-001422, Hawaii-N/A, Illinois-CO 01-025537, Indiana-000103829-000, Kansas- 177-257-3SO, Kentucky-45, Louisiana-N/A, Maine- CO-1247, Maryland-102, Massachusetts-029317, Michigan-MICS 10326, Minnesota-N/A, Mississippi- 100000294, Missouri- CO-021-87, New Hampshire-5006, New Jersey- CH-0581900, New Mexico-N/A, New York- 1/30/1965, North Carolina- SL000618, North Dakota-7894, Ohio- 01-0239, Oklahoma- N/A, Oregon- 16402, Pennsylvania- No. 21, Rhode Island-95-233, South Carolina-641, Tennessee-5104, Utah- 6536093-Char, Virginia-N/A, Washington-7664, West Virginia-N/A, Wisconsin- 3020-800. |
| Form 990, Part VI, Section C, Line 19 | The following information is available on the American Diabetes Associations website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, Conflict of Interest Policy. |
| Form 990, Part VII, Section A, Line 1a | The Chief Executive Officer of the Association is a non-voting member of the Board of Directors. |
| Form 990, Part VI, Section A, Line 4 | The bylaws of the American Diabetes Association were revised in 2018. Changes to the bylaws include 1 mission statement added, 2 principal office location changed to Arlington, Virginia, 3 Diabetes Epidemic Action Council removed from delegates, 4 categories of non-voting members expanded, and 5 Chief Scientific, Medical and Mission Officer added to Board of Directors. |
| Form 990, Part VI, Section A, Line 9 | Employment term for Tracey D Brown, Chief Executive Officer, started on June 1, 2018. Employment term for Martha Parry Clark, Interim Chief Executive Officer, ended on May 31, 2018. Employment term for Eloise Scavella, Chief Operating Officer, started on July 23, 2018. Employment term for Corey Gordon, Chief Development and Stewardship Officer, ended on January 31, 2018. Employment term for Michael Eisenstein, SVP Products, ended on July 11, 2018. Employment term for Chris Boynton, VP Eastern Division, ended on July 11, 2018. |
| Software ID: | 18007340 |
| Software Version: | 19.1.1.0 |